CD44 and breast carcinoma: Similarly, McFarlane et al., described that CD44 expression was associated with high grade (p = 0.046), ER-negative (p = 0.001), PgR-negative status (p = 0.029) and higher recurrence rates in their 448 breast cancer cases [11].